Company: INMB
Filing Date: 2025-06-30
Form Type: 424B5
Source: 0001213900-25-059298
Chunk: 32

Company: Inmune Bio, Inc.
Filing Date: 2025-06-30
Form: 424B5
Chunk 32
---
 issued under a separate warrant agreement
to be entered into between a warrant agent specified in the agreement and us. The warrant agent will act solely as our agent in connection
with the warrants of that series and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial
owners of warrants. This summary of some provisions of the securities warrants is not complete. You should refer to the securities warrant
agreement, including the forms of securities warrant certificate representing the securities warrants, relating to the specific securities
warrants being offered for the complete terms of the securities warrant agreement and the securities warrants. The securities warrant
agreement, together with the terms of the securities warrant certificate and securities warrants, will be filed with the SEC in connection
with the offering of the specific warrants.

The applicable prospectus
supplement will describe the following terms, where applicable, of the warrants in respect of which this prospectus is being delivered:

| ● | the title of the warrants; |

| ● | the aggregate number of the warrants; |

| ● | the price or prices at which the warrants will be issued; |

| ● | the designation, amount and terms of the offered securities 
 purchasable upon exercise of the warrants;                  |

| ● | if applicable, the date on and after which the warrants and                                       
 the offered securities purchasable upon exercise of the warrants will be separately transferable; |

| ● | the terms of the securities purchasable upon exercise of such                         
 warrants and the procedures and conditions relating to the exercise of such warrants; |

| ● | any provisions for adjustment of the number or amount of securities             
 receivable upon exercise of the warrants or the exercise price of the warrants; |

| ● | the price or prices at which and currency or currencies in                               
 which the offered securities purchasable upon exercise of the warrants may be purchased; |

| ● | the date on which the right to exercise the warrants shall 
 commence and the date on which the right shall expire;     |

| ● | the minimum or maximum amount of the warrants that may be 
 exercised at any one time;                                |

| ● | information with respect to book-entry procedures, if any; |

| ● | if appropriate, a discussion of Federal income tax consequences; 
 and                                                              |

| ● | any other material terms of the warrants, including terms,                        
 procedures and limitations relating to the exchange and exercise of the warrants. |

Warrants for the purchase
of common stock or preferred stock will be offered and exerc